Announced Wed, 12 Aug · 16:51 IST
Crestchem Q1 FY27 results: Revenue up 82%, PAT jumps 182% YoY
Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+6.9%1-day move
₹128.10
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+6.9+0.7-3.2-3.1-0.9—————
Up moveDown movePending
AI summary
Crestchem posted Q1 FY27 standalone revenue of Rs 917.89 lacs, up 82% YoY from Rs 503.09 lacs. PAT surged 182% YoY to Rs 98.29 lacs (vs Rs 34.80 lacs). EPS stood at Rs 3.28 vs Rs 1.16. Total income grew to Rs 937.49 lacs. Consolidated PAT was Rs 94.16 lacs, including subsidiary Oleo Biosciences which posted a loss of Rs 4.13 lacs. Auditors issued an unqualified limited review.
Likely market impact
Sharp YoY growth in revenue and profits signals strong operational momentum. Subsidiary loss is small and immaterial overall.